F. Caiment

In the department of Toxicogenomics, his main expertise is in the recently emerging next-generation sequencing (NGS) technology, which allows sequencing complete genome or transcriptome of any biological material for unlimited applications. He was leading RNA-Seq activities of the EU FP7 HeCaToS project (14 partners) as well as the currently running Horizon 2020 Eu-ToxRisk (39 partners). His sequencing expertise is not limited to Europe, notably with my participation in the international MAQC consortium or his leading role of the sequencing team in the initiative of the OECD to establish a transcriptomics reference analysis framework for the regulatory agencies. He is pursuing two main research themes: the investigation of new possible mechanisms of toxicity of compounds by the study of every component of genome (isoforms, circRNAs,